Table: Brightpath Biotherapeutics - Q1 parent results

BrightPath Biotherapeutics Co

09/08/2019 07:01

Aug 9 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2019        Jun 30, 2018      Mar 31, 2020  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             0 mln                                 4 mln     
                                                       (-97.4 pct)  
  Operating     loss 423 mln                            loss 2.42   
  Recurring     loss 421 mln                            loss 2.42   
  Net           loss 417 mln                            loss 2.44   
  EPS           loss 9.94 yen                        loss 58.03 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T